Subscribe to RSS - Paragon Ventures

Paragon Ventures

Lincare buys provider with scale

 - 
09/07/2018

MIDDLEBURY, Conn. – When Lincare bought J&L Medical Services, it got a “gem,” says one industry analyst.

J&L Medical sells to Lincare

 - 
09/05/2018

MIDDLEBURY, Conn. – J&L Medical Services has sold to Lincare, it was announced Sept. 4.

M&A: Look beyond dollar signs

Q. How should I vet each offer I received to determine which to accept?
 - 
08/29/2018

A. It may surprise you to learn that many times a high offered price is not always the best deal. Many other factors must be considered before accepting an offer. 

M&A: Don't skip to last chapter

Q. What is exit planning and how do I explore the strategic options for my HME business?
 - 
06/26/2018

 A.

M&A: Be forthright and professional

Q. Some of my employees heard a rumor that we may sell our company. How do I deal with these rumors and what and when should I tell them?
 - 
05/29/2018

A. The era of competitive bidding has caused 40% of HME businesses to close or merge over the past decade. Sometimes a sale or merger is the only option for a business owner to scale for survival and realize a return on a lifetime of work.

Marsallo: ‘Still a lot of movement for companies’

 - 
02/27/2018

When it comes to home medical equipment, Tony Marsallo has been there, done that.

Short takes: Brightree, Paragon Ventures

 - 
01/19/2018

Brightree has extended its membership agreement with VGM & Associates through 2020. The agreement ensures VGM members will continue to save money through discounted access to Brightree’s core software solutions.

Short takes: BioScrip, Paragon Ventures, Stratice Healthcare, Invacare

 - 
10/05/2017

BioScrip is now dispensing and administering Radicava, the first treatment option for ALS approved by the U.S. Food and Drug Administration in more than 20 years…Paragon Ventures, a healthcare M&A firm, has launched paragonventures.com.

In brief: NCART fights for separate billing, F&P responds to potential Trump tariff on Mexico

 - 
01/27/2017

WASHINGTON – NCART has formed a work group and developed an issue paper in response to CMS’s decision not to allow separate billing for titanium wheelchair frames and heavy duty upgrades.

Moneyline: PharMerica, FOSRx make buys

 - 
01/25/2017

LOUISVILLE, Ky. – Amerita, the Specialty Infusion Division of PharMerica, has acquired Fairlawn, N.J.-based Nextron, a provider of certain specialty medications in the home. The move allows Amerita to further its expansion in the eastern United States.

Pages